StockData
ABVC BioPharma, Inc. logo

ABVC BioPharma, Inc. (ABVC) stock

ABVCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ECOC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 2/30
$0.91−0.03 (-3.15%)

Close on Nov 18, 2026Market cap $24.27MP/E –Yield –

ABVC BioPharma revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

ABVC BioPharma's revenue for the twelve months ending Dec 31, 2024 was $296.00K, up 94.2% year over year. For fiscal 2025 it was $296.00K, up 0.0% from the year before. Over ten years it grew 57.3% a year on average. The highest annual figure on record is $969.78K in fiscal 2022.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$296.00K0.0%
FY2024Dec 31, 2024$296.00K+94.2%
FY2023Dec 31, 2023$152.43K-84.3%
FY2022Dec 31, 2022$969.78K+172.6%
FY2021Dec 31, 2021$355.80K-26.3%
FY2020Dec 31, 2020$483.05K-31.2%
FY2019Dec 31, 2019$701.72K–
FY2014Sep 18, 2014$0-100.0%
FY2013Sep 30, 2013$7.79K+36.3%
FY2012Sep 30, 2012$5.71K+79.1%
FY2011Sep 30, 2011$3.19K-78.5%
FY2010Sep 30, 2010$14.86K–

Quarterly revenue

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2025CQ3 2025Sep 30, 2025$795.95K+65953.9%
Q4 FY2024CQ4 2024Dec 31, 2024$1.97K-9.2%
Q3 FY2024CQ3 2024Sep 30, 2024$389.28K+2350.7%
Q2 FY2024CQ2 2024Jun 30, 2024$117.14K+1817.5%
Q1 FY2024CQ1 2024Mar 31, 2024$1.21K-99.1%
Q4 FY2023CQ4 2023Dec 31, 2023$2.17K-99.6%
Q3 FY2023CQ3 2023Sep 30, 2023$15.88K-62.4%
Q2 FY2023CQ2 2023Jun 30, 2023$6.11K-98.0%
Q1 FY2023CQ1 2023Mar 31, 2023$128.27K+399.9%
Q4 FY2022CQ4 2022Dec 31, 2022$588.99K+494.9%
Q3 FY2022CQ3 2022Sep 30, 2022$42.27K+34.4%
Q2 FY2022CQ2 2022Jun 30, 2022$312.86K+18.9%
Q1 FY2022CQ1 2022Mar 31, 2022$25.66K-58.7%
Q3 FY2021CQ3 2021Sep 30, 2021$99.00K-14.3%
Q2 FY2021CQ2 2021Jun 30, 2021$31.44K-86.1%
Q1 FY2021CQ1 2021Mar 31, 2021$263.15K+234.0%
Q4 FY2020CQ4 2020Dec 31, 2020$62.19K-37.8%
Q3 FY2020CQ3 2020Sep 30, 2020$115.55K-41.6%
Q2 FY2020CQ2 2020Jun 30, 2020$226.51K+18.1%
Q1 FY2020CQ1 2020Mar 31, 2020$78.79K-62.9%
Q4 FY2019CQ4 2019Dec 31, 2019$99.96K+11.1%
Q3 FY2019CQ3 2019Sep 30, 2019$197.73K–
Q2 FY2019CQ2 2019Jun 30, 2019$191.78K+174.0%
Q1 FY2019CQ1 2019Mar 31, 2019$212.24K–
Q3 FY2017CQ2 2017Jun 30, 2017$90.00K–
Q2 FY2017CQ1 2017Mar 31, 2017$0–
Q1 FY2017CQ4 2016Dec 31, 2016$70.00K–
Q3 FY2015CQ2 2015Jun 30, 2015$0–

More ABVC BioPharma figures

See a number that looks wrong?